StockDuty ← Dashboard Aug 18, 2026 10:00 PM ET
SignalCorporate

GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles

27.3% revenue growth and doubled AI drug discovery business signal strong catalysts.

What changed
Why it matters
27.3% revenue growth and doubled AI drug discovery business signal strong catalysts.
Sources
eodhd
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →STRATEGY EXPANDS STRC PREFERRED STOCK BUYBACK PROGRAM; SHARES DOWN - SEEKINGALPHA →